Executive summary

A market pulled by demography, priced by reform.
Total market 2023
JPY 6.0trn
USD ~40 bn · 3rd largest globally
MHLW 2024
Population aged 65+
29.3%
36.3 mn people · highest globally
Govt stats 2024
FY2026 materials price
−0.01%
First reverse-margin uplift introduced
Chuikyo 2025
Import dependency 2023
55%
Imports JPY 3.32 trn · +13.8% YoY
Kira estimates

Demand is demographically non-discretionary

Japan crossed 36.3 million people aged 65 and over — 29.3% of the population in 2024 [Govt stats 2024], with more than one in ten now aged 80 or older. The old-age dependency ratio is projected to climb from 39% in 2020 to 71% by 2040 [Govt stats 2024]. This cohort drives the highest-utilisation device categories — diagnostic imaging, cardiovascular intervention, orthopedic implants, and in-vitro diagnostics — independent of the economic cycle, anchoring a market that grows even as the total population shrinks.

Reform redraws the price floor

The FY2026 medical fee revision pairs a +3.09% increase in the fee body — the first positive whole-package revision in over a decade — with a marginal −0.01% materials price change [Chuikyo 2025]. More structurally, Chuikyo approved a first-ever reverse-margin (gyaku-zaya) correction: where hospitals' purchase price has exceeded the reimbursed price under a weak yen, certain device categories now receive an actual-price-based uplift [Chuikyo 2025]. The signal is a shift from pure cost containment toward supply-security and clinical-value pricing.

Japan medical device market sizing
Japan · USD bn · 2021–2030F
USD BN
0 20 40 60 80 36 40 42 48 54 62 2021 2023 2025E 2027F 2028F 2030F Actual/Estimate Forecast
SOURCE: MHLW PRODUCTION STATISTICS, KIRA TRIANGULATION · KIRA RESEARCH 2026
MHLW 2024 = MHLW Pharmaceutical & Medical Device Production Statistics (2023 data) · Chuikyo 2025 = Central Social Insurance Medical Council FY2026 reform outline · Govt stats 2024 = national population statistics